HSA | FSA CARDS ARE NOW ACCEPTED

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Standard peptide protocols are built on population averages. They're designed to produce results across the broadest range of people — reasonable starting points, backed by legitimate research. But when your genetic variants place you outside that average, a standard protocol leaves real results on the table. And you won't know which side of that line you're on until you look.

That's the problem the PlexusDx Precision Peptide Genetic Test is built to solve. The Peptide Pathways Report delivers 150 genetic insights across 14 health pathways and 49 peptides — mapping your specific DNA variants to the compounds most studied in the context of your biology, so your protocol starts from your genetics rather than the population's.

What a Standard Protocol Cannot See

A standard protocol for growth hormone support might recommend GHRP-2 or Ipamorelin. Both are well-researched. Both stimulate the growth hormone secretagogue receptor — encoded by the GHSR gene. But GHSR rs572169 variants influence receptor sensitivity, and how efficiently that stimulation translates into measurable downstream effects at the cellular level varies by genotype.

Without knowing your GHSR variant, you're designing a protocol around what works for most people. With it, you know whether growth hormone secretagogues represent a high-priority genetic alignment for your biology — or a lower-priority starting point — before you spend a dollar.

That same gap exists across all 14 pathways and all 49 peptides in the report. A few specific examples:

  • 💪 Muscle Growth: MSTN rs1805086 encodes myostatin — a natural brake on skeletal muscle development. Your variant determines how much biological leverage peptides like Follistatin 344, CJC-1295, and IGF-1 LR3 have to work with. Two people with identical training and the same protocol can get different results because one has a more favorable myostatin genotype than the other.
  • 🧠 Cognition: BDNF rs6265 — the Val66Met variant — is one of the most replicated SNPs in neuroscience. It influences how efficiently the brain secretes brain-derived neurotrophic factor under activity and stress. This single variant appears across the cognition, mood, brain health, and inflammation pathways in the Peptide Pathways Report, connecting to Semax, Dihexa, Selank, PE-22-28, Pinealon, and VIP. Knowing your BDNF status is foundational to evaluating any nootropic peptide approach.
  • ⚡ Energy Metabolism: PPARGC1A rs8192678 encodes PGC-1α — a master regulator of mitochondrial biogenesis. Variants here influence how efficiently your cells create new mitochondria under metabolic stress. This directly informs the value of MOTS-C and SS-31, two peptides specifically studied in the context of mitochondrial health and cellular energy production.
  • ⏳ Longevity: TERT rs2736100 influences telomerase activity — the enzyme responsible for maintaining telomere length, one of the most studied biomarkers of cellular aging. This variant appears in the longevity pathway for Epitalon, a peptide studied for its potential influence on telomerase expression. Your TERT status is directly relevant to how you evaluate this compound.
  • 🛡️ Immunity: TNF rs1799964 and rs1800629 shape how your immune system produces tumor necrosis factor, influencing your inflammatory baseline before any immune-modulating peptide enters the picture. These two variants appear across five separate pathways in the report — immunity, inflammation, skin health, tissue repair, and longevity — connecting to Thymalin, Thymosin Alpha-1, KPV, BPC-157, TB-500, GHK-Cu, and Vilon.
  • 😊 Mood: OXTR rs53576 encodes the oxytocin receptor and influences how powerfully oxytocin-pathway signaling registers. If you're evaluating oxytocin for stress resilience, social wellbeing, or mood regulation, your receptor sensitivity genotype matters. A standard protocol doesn't ask.

Why Depth of Panel Matters

Not all genetic peptide analysis is equivalent. The difference between a report that mentions a few relevant genes and one that delivers 150 genetic insights across 14 pathways is the difference between a general impression and a precision roadmap.

The Peptide Pathways Report analyzes 57 unique SNPs across 48 distinct genes. Every variant was selected for a mechanistic reason — because it has a documented biological relationship to the pathway a specific peptide targets. That's not general wellness genomics. It's pathway-specific intelligence built for protocol decisions.

To illustrate how that depth plays out across three genes that carry particular cross-pathway significance:

SIRT1 (rs12778366 and rs3758391) encodes Sirtuin-1, a protein deacetylase that regulates cellular energy sensing, stress response, and longevity signaling through pathways including AMPK and PGC-1α. SIRT1 appears in both the energy metabolism pathway — relevant to MOTS-C and SS-31 — and the longevity-aging pathway — relevant to Epitalon. If you're evaluating both energy and longevity peptides simultaneously, your SIRT1 status is a shared data point that informs both.

HLA-DQA1 rs2187668 sits within the human leukocyte antigen system, one of the most genetically variable regions in the human genome, responsible for immune self-recognition. Variants here influence immune responsiveness across autoimmune and inflammatory contexts. HLA-DQA1 appears across the immunity (Thymosin Alpha-1), inflammation (KPV), and longevity (Vilon) pathways — three distinct peptide categories unified by a single genetic thread.

FOXO3 rs2802292 is the gene most consistently associated with exceptional human longevity across independent centenarian population studies. It influences cellular stress resistance, autophagy regulation, and inflammatory tone. FOXO3 appears across the longevity (Epitalon, FOXO4-DRI), skin health (OS-01), and immunity (Thymalin) pathways — making it one of the most cross-pathway relevant variants in the entire 150-insight report.

From Population Average to Personal Baseline

Here is what changes when you have genetic data before building a protocol.

Without it: the conversation starts with "what do most people use for this goal?" and works backward to you through trial and observation.

With it: the conversation starts with your MSTN, IGF1, GHSR, and PPARGC1A variants — and works forward to which muscle growth peptides are most biologically aligned with your specific profile, before any compound is introduced.

That is a fundamentally different conversation. It is also a more responsible one. Peptide protocols are not low-stakes experiments. They represent a meaningful commitment of money, time, and physiology. The Precision Peptide Genetic Test exists because that commitment deserves a genetic foundation — not a population average.

This is why the report covers 14 pathways, 49 peptides, and 150 genetic insights rather than a handful of the most popular compounds. Your health goals don't fit in one category. Your genetic data shouldn't either.

The Pathways Your Protocol May Be Missing

Most people approaching peptides for the first time have one or two goals in mind — body composition, longevity, cognitive performance. What the Peptide Pathways Report frequently reveals is that the genetic picture is broader than the initial goal suggested.

Someone pursuing weight management variants in FTO, TCF7L2, MC4R, PPARG, ADIPOQ, and LEPR may also carry variants in FOXO3 and TERT that make the longevity pathway — Epitalon, FOXO4-DRI — highly relevant to their long-term biology. Someone focused on muscle growth through IGF1 and MSTN may carry BDNF variants that make cognitive support through Semax or Dihexa a logical parallel consideration.

The report doesn't prescribe these connections. It surfaces them — so you and your provider can make informed decisions about scope, sequencing, and priority rather than discovering gaps after months of a narrowly focused protocol.

What Personalized Actually Means

The word "personalized" is used loosely in health and wellness. A protocol built around your age, weight, and stated goals is not personalized — it is categorized. True personalization in the peptide context means your protocol accounts for the genetic variants that determine how the relevant biological mechanisms function in your specific body.

That requires data you can only get by testing. The Peptide Pathways Report provides 150 data points — 57 SNPs across 48 genes — run on the Illumina Global Screening Array through CLIA-certified laboratories. Because your DNA never changes, those 150 insights remain relevant across every protocol decision you make going forward. Not just today's goal. Every goal.

Frequently Asked Questions About Personalized Peptide Protocols

What makes a peptide protocol truly personalized?

A genuinely personalized peptide protocol accounts for the genetic variants that influence how specific biological mechanisms function in your body — not just your age, weight, or stated goals. The PlexusDx Peptide Pathways Report delivers 150 genetic insights across 14 pathways and 49 peptides, giving you and your provider the variant-level data needed to align a protocol with your actual biology rather than population averages.

Can genetic testing predict exactly how I'll respond to a peptide?

Genetic testing identifies biological tendencies — not guaranteed individual outcomes. Variants in receptor genes, signaling pathway components, and metabolic enzymes create statistical associations with how different peptides may interact with your biology. These insights help inform smarter protocol decisions, giving you and your provider a stronger starting point than population averages alone. Genetics is one layer of a complete clinical picture.

Why does the Peptide Pathways Report cover 14 pathways instead of just the most popular ones?

Because your biology doesn't operate in a single category. Genetic variants often carry relevance across multiple pathways simultaneously — FOXO3 appears in longevity, skin health, and immunity; BDNF appears in cognition, mood, brain health, and inflammation; TNF appears across five separate pathways. A report limited to a few popular compounds would miss the cross-pathway connections that often represent the most significant genetic findings for a given person.

How is the Peptide Pathways Report different from what a practitioner already knows?

A practitioner brings clinical expertise and observational experience. The Peptide Pathways Report brings your specific genetic data — 57 SNPs across 48 genes — that no clinical observation can substitute for. The combination of practitioner expertise and your genetic baseline is more powerful than either alone. The report is designed to enhance that conversation, not replace it.

Is there value in testing if I'm already working with a peptide practitioner?

Significant value. The 150 genetic insights in the Peptide Pathways Report give your practitioner variant-level data they otherwise don't have access to — informing which compounds in your current protocol are well-matched to your biology, which pathways may warrant addition, and how your genetic profile should shape sequencing and prioritization going forward. Most practitioners working in precision health will find it a useful clinical input.

How many genes and SNPs does the report actually analyze?

The Peptide Pathways Report analyzes 57 unique SNPs across 48 distinct genes. Every variant was selected for its mechanistic relevance to a specific peptide pathway — not general wellness associations. The test is run on the Illumina Global Screening Array through CLIA-certified laboratories, the same platform used across clinical genomics research.

Do I need to retest as new peptide research emerges?

No. Your DNA doesn't change, so the 57 SNPs and 48 genes analyzed in your report remain the same permanent reference point regardless of how the peptide research landscape evolves. As new compounds and pathway findings emerge, your existing genetic data provides the foundation to evaluate them — without retesting.

The Precision Peptide Genetic Test and Peptide Pathways Report are designed for wellness education and health optimization — not for the diagnosis, treatment, or prevention of any disease. Always consult a qualified healthcare provider before beginning any peptide protocol.

If the genetic pathways in this post are relevant to your health goals, these are your recommended next steps:

🧬 Genetic Tests:

📄 Genetic Report:

👉 New to genetic peptide testing? Start with What Is Genetic Peptide Testing — And Why It Matters Before You Start a Protocol, then explore the full PlexusDx Education Hub for more precision health resources.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.